20. Results of surgery for curettage and bone graft to treat bone giant cell tumors
Main Article Content
Abstract
Extensive curettage and bone grafting are common methods for treatment of bone giant cell tumors (GCT). The success rate of this method in different studies varies greatly. Objectives: to analyze the results of 24 cases treated using extensive curettage and bone grafting. Methods: Design of an uncontrolled clinical intervention study on 24 cases of bone GCT, of which 21 new cases and 3 recurrent cases were treated by curettage and autologous bone grafting. Evaluation of GCT stage was based on X-ray and computed tomography. Results: after a follow-up period of more than 2 years, 100% of patients achieved healed bone graft site, 2 patients had recurrent tumors at the previous tumor site representing 8.3%. With lesions at the upper extremities, the average MSTS score was 24.5, of which the lowest was 19, the highest was 28; The mean MSTS score of lesions in the lower extremities was 23.1, of which the lowest was 17 and the highest was 25. Conclusion: Curettage and bone grafting is an effective method in the treatment of GCT. Patient selection as well as strict adherence to the principles of tumor surgery will reduce the recurrence rate.
Article Details
Keywords
giant cell tumor, bone graft curettage, pathological bone fractures
References
2. Rao PT. Management of giant cell tumor of bone. Kini memorial oration. Indian J Orthop. 1993;27:96-100.
3. Campanacci M. Giant cell tumor. In: Gaggi A, editor. Bone and soft-tissue tumors. Bologna, Italy: Springer-Verlag; 1990.pp.17-53.
4. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69(1):106-114.
5. Mohaidat ZM, Al-Jamal HZ, Bany-Khalaf AM, Radaideh AM, Audat ZA. Giant cell tumor of bone: Unusual features of a rare tumor. Rare Tumors. 2019;11:2036361319878894. Published 2019 Sep 25. doi: 10.1177/ 2036361319878894.
6. Verschoor AJ, Bovée JVMG, Mastboom MJL, Sander Dijkstra PD, Van De Sande MAJ, Gelderblom H. Incidence and demographics of giant cell tumor of bone in The Netherlands: First nationwide pathology registry study. Acta Orthop. 2018;89(5):570-574. doi: 10.1080/17453674.2018.1490987.
7. Saikia KC, Bhuyan SK, Borgohain M, Saikia SP, Bora A, Ahmed F. Giant cell tumour of bone: an analysis of 139 Indian patients. J Orthop Sci. 2011;16(5):581-588. doi: 10.1007/s00776-011-0033-7.
8. Errani C, Ruggieri P, Asenzio MA, et al. Giant cell tumor of the extremity: A review of 349 cases from a single institution. Cancer Treat Rev. 2010;36(1):1-7. doi: 10.1016/j.ctrv.2 009.09.002.
9. Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011;469(2):591-599. doi: 10.1007/s11999-010 -1501-7.
10. Nguyễn Văn Hiến, Diệp Thế Hòa, Đoàn Long Vân. Kết quả chức năng sau cắt đoạn xương mang bướu và ghép chỏm xương mác tự thân không có cuống mạch máu kèm tái tạo dây chằng quay trụ dưới trong điều trị bướu đại bào đầu dưới xương quay. Tạp chí Y học Việt Nam. 2021;500(2).
11. Asavamongkolkul A, Eamsobhana P, Waikakul S, Phimolsarnti R. The outcomes of treatment of giant cell tumor of bone around the knee. J Med Assoc Thai. 2012;95 Suppl 9:S122-S128.
12. Giteris S, Mallin BA, Piasecki P, Turner F. Intralesional excision compared with en bloc resection for giant-cell tumors of bone. Am J Bone Joint Surg. 1993;75:pg.1648-55.
13. Barik S, Jain A, Ahmad S, Singh V. Functional outcome in giant cell tumor of distal radius treated with excision and fibular arthroplasty: a case series. Eur J Orthop Surg Traumatol. 2020;30(6):1109-1117. doi: 10.1007/00590-020-02679-2.